dicarbethoxydihydrocollidine has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Griensven, LJ; Verhoeven, HA | 1 |
| Beger, RD; Chou, MW; Fu, PP; Wang, YP; Yan, J | 1 |
2 other study(ies) available for dicarbethoxydihydrocollidine and Neoplasms
| Article | Year |
|---|---|
Flow cytometric evaluation of the effects of 3-bromopyruvate (3BP) and dichloracetate (DCA) on THP-1 cells: a multiparameter analysis.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dicarbethoxydihydrocollidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Membrane Potential, Mitochondrial; Neoplasms; Principal Component Analysis; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvates; Reactive Oxygen Species | 2012 |
Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo.
Topics: Animals; Dicarbethoxydihydrocollidine; DNA Adducts; Female; Liver; Monocrotaline; Neoplasms; Pyrrolizidine Alkaloids; Rats; Rats, Inbred F344 | 2005 |